Masaru Matsuda is SVP, General Counsel of HALOZYME THERAPEUTICS, INC.. Currently has a direct ownership of 20,049 shares of HALO, which is worth approximately $982,401. The most recent transaction as insider was on Sep 04, 2021, when has been sold 3,412 shares (Common Stock) at a price of $42.22 per share, resulting in proceeds of $144,055. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 20K
0% 3M change
0% 12M change
Total Value Held $982,401

Masaru Matsuda Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 04 2021
SELL
Payment of exercise price or tax liability
$144,055 $42.22 p/Share
3,412 Reduced 14.54%
20,049 Common Stock
Sep 04 2021
BUY
Exercise of conversion of derivative security
-
6,883 Added 22.68%
23,461 Common Stock
Feb 12 2021
SELL
Payment of exercise price or tax liability
$102,022 $49.84 p/Share
2,047 Reduced 10.99%
16,578 Common Stock
Feb 12 2021
BUY
Exercise of conversion of derivative security
-
4,129 Added 18.15%
18,625 Common Stock
Feb 10 2021
SELL
Payment of exercise price or tax liability
$162,072 $50.6 p/Share
3,203 Reduced 18.1%
14,496 Common Stock
Feb 10 2021
BUY
Exercise of conversion of derivative security
-
6,257 Added 26.12%
17,699 Common Stock

Also insider at

ARQT
Arcutis Biotherapeutics, Inc. Healthcare
MM

Masaru Matsuda

SVP, General Counsel
San Diego, CA

Track Institutional and Insider Activities on HALO

Follow HALOZYME THERAPEUTICS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HALO shares.

Notify only if

Insider Trading

Get notified when an Halozyme Therapeutics, Inc. insider buys or sells HALO shares.

Notify only if

News

Receive news related to HALOZYME THERAPEUTICS, INC.

Track Activities on HALO